Author:
Nevala Wendy K.,Butterfield John T.,Sutor Shari L.,Knauer Daniel J.,Markovic Svetomir N.
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Armitage, J. O. & Weisenburger, D. D. New approach to classifying non-Hodgkin’s lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin’s Lymphoma Classification Project. J Clin Oncol 16, 2780–2795 (1998).
2. Dotan, E., Aggarwal, C. & Smith, M. R. Impact of Rituximab (Rituxan) on the Treatment of B-Cell Non-Hodgkin’s Lymphoma. P T 35, 148–157 (2010).
3. Shankland, K. R., Armitage, J. O. & Hancock, B. W. Non-Hodgkin lymphoma. Lancet 380, 848–857 (2012).
4. Engelhard, M. Anti-CD20 Antibody treatment of Non-Hodgkin Lymphomas. Clin Immunol (2016).
5. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2016. CA Cancer J Clin 66, 7–30 (2016).
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献